St. Joseph's Children's Hospital of Tampa Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
1996
NCT00002827
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Alternative names

St. Joseph's Hospital, Florida

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cardiotoxicity (Phase 3)

Hodgkin Disease (Phase 3)

Lymphoma (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 7